Two Sigma Investments’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,000
Closed -$221K 4523
2021
Q3
$221K Sell
3,000
-9,000
-75% -$675K ﹤0.01% 3896
2021
Q2
$801K Buy
12,000
+7,800
+186% +$521K ﹤0.01% 2678
2021
Q1
$312K Buy
4,200
+200
+5% +$15.2K ﹤0.01% 3296
2020
Q4
$291K Buy
+4,000
New +$282K ﹤0.01% 2887
2018
Q4
Sell
-8,000
Closed -$328K 3209
2018
Q3
$328K Buy
+8,000
New +$323K ﹤0.01% 2713
2018
Q2
Sell
-50,800
Closed -$1.9M 3447
2018
Q1
$1.9M Buy
+50,800
New +$2.05M 0.01% 1562

Other funds holding HOLX

Two Sigma Investments's HOLX Position: Q1 2026 in Review

Two Sigma Investments increased its Hologic (HOLX) stake by 286% in Q1 2026, buying an estimated $18.3M and bringing the position to 328,504 shares worth $24.8M. The position accounts for 0.02% of the portfolio, ranked #827.

Two Sigma Investments first reported a position in HOLX in Q3 2013 and has held it in 46 quarters since. The position peaked at $60.2M in Q4 2015. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Two Sigma Investments held 328,504 shares of Hologic worth $24.8M as of Q1 2026.
  • Two Sigma Investments bought 243,300 Hologic shares in Q1 2026, an estimated $18.3M.
  • Hologic made up 0.02% of Two Sigma Investments's portfolio in Q1 2026, its #827 holding.
  • Two Sigma Investments first reported a position in Hologic in Q3 2013 and has held it in 46 quarters since.
  • Two Sigma Investments's Hologic position peaked at $60.2M in Q4 2015.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.